• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Kynureninase (KYNU)

The expression region of this recombinant Human KYNU covers amino acids 1-307. This KYNU protein is expected to have a theoretical molecular weight of 61.6 kDa. This protein is generated in a e.coli-based system. Fusion of the N-terminal GST tag into the KYNU encoding gene fragment was conducted, allowing for easier detection and purification of the KYNU protein in subsequent stages.human kynureninase (KYNU) is a crucial enzyme in the tryptophan catabolic pathway, catalyzing the conversion of kynurenine to anthranilic acid. KYNU plays a pivotal role in regulating the levels of neuroactive kynurenine metabolites, influencing neurotransmission and immune responses. In neurobiology, KYNU is implicated in neurodegenerative diseases and psychiatric disorders due to its involvement in kynurenine metabolism. In immunology research, KYNU modulates immune tolerance and inflammation. Furthermore, KYNU's role in cancer metabolism underscores its significance in oncology. Investigating KYNU provides insights into tryptophan metabolism, offering potential applications in neurology, immunology, and cancer research, with implications for therapeutic strategies targeting these pathways.

ACP02128

The expression region of this recombinant Human KYNU covers amino acids 1-307. This KYNU protein is expected to have a theoretical molecular weight of 61.6 kDa. This protein is generated in a e.coli-based system. Fusion of the N-terminal GST tag into the KYNU encoding gene fragment was conducted, allowing for easier detection and purification of the KYNU protein in subsequent stages.human kynureninase (KYNU) is a crucial enzyme in the tryptophan catabolic pathway, catalyzing the conversion of kynurenine to anthranilic acid. KYNU plays a pivotal role in regulating the levels of neuroactive kynurenine metabolites, influencing neurotransmission and immune responses. In neurobiology, KYNU is implicated in neurodegenerative diseases and psychiatric disorders due to its involvement in kynurenine metabolism. In immunology research, KYNU modulates immune tolerance and inflammation. Furthermore, KYNU’s role in cancer metabolism underscores its significance in oncology. Investigating KYNU provides insights into tryptophan metabolism, offering potential applications in neurology, immunology, and cancer research, with implications for therapeutic strategies targeting these pathways.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02128 Target NameKYNU
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range1-307aaMol Weight61.6 kDa
Protein LengthFull Length of Isoform 2PurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ16719
Background Information
  • Uniprot Id

    Q16719

  • Target Species

    Human

  • Target Name

    KYNU

  • Target Full Name

    Kynureninase

  • Target Function

    Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3-hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3-hydroxyanthranilic acid (3-OHAA), respectively. Has a preference for the L-3-hydroxy form. Also has cysteine-conjugate-beta-lyase activity.

  • Target Involvement

    Hydroxykynureninuria (HYXKY); Vertebral, cardiac, renal, and limb defects syndrome 2 (VCRL2)

  • Target Subcellular Location

    Cytoplasm, cytosol.

  • Target Protein Families

    Kynureninase family

  • Target Tissue Specificity

    Expressed in all tissues tested (heart, brain placenta, lung, liver, skeletal muscle, kidney and pancreas). Highest levels found in placenta, liver and lung. Expressed in all brain regions.

  • Target Research Area

    Signal Transduction

  • Target Synonyms

    kynU; KYNU_HUMAN; kynureninase (L-kynurenine hydrolase); Kynureninase; L-kynurenine hydrolase

  • Target Background

    Kynureninase is a pyridoxal-5'-phosphate (pyridoxal-P) dependent enzyme that catalyzes the cleavage of L-kynurenine and L-3-hydroxykynurenine into anthranilic and 3-hydroxyanthranilic acids, respectively. Kynureninase is involved in the biosynthesis of NAD cofactors from tryptophan through the kynurenine pathway. Alternative splicing results in multiple transcript variants.

Inquire Recombinant Human Kynureninase (KYNU) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification